fluticasone furoate/umeclidinium/vilanterol

Thu, 28 Apr 2022 14:11:50 -0400
​Trelegy Ellipta 100/62.5/25 mcg and 200/62.5/25 mcg are indicated for the long-term, once-daily, maintenance treatment of asthma in patients aged 18 years and older who are not adequately controlled with a maintenance combination of a medium or high dose of an Inhaled corticosteroid (ICS) and Long-acting beta-2 agonist (LABA).